What Serosurveys tell us about India's COVID-19 caseload

According to official reports, COVID-19 has infected 8.41 million Indians as of November 2020. Molecular diagnostics tests (RT-PCR/TruNat/CBNAAT) and rapid tests (antigen) have so far been used for testing active infections. However, experts argue that this number may be an under-reporting of the true disease burden.

In fact, results of serosurveys across the country indicate a serious gap between the estimated number of cases and reported number of cases.

This video explains in brief what Serosurveys are and how they can help us tailor our public health response to COVID-19.

For a detailed graphical analysis of this topic, download our discussion document here.